tadalafil has been researched along with baohuoside i in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (baohuoside i) | Trials (baohuoside i) | Recent Studies (post-2010) (baohuoside i) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 154 | 1 | 132 |
| Protein | Taxonomy | tadalafil (IC50) | baohuoside i (IC50) |
|---|---|---|---|
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.7 | |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.7 | |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, S; Huang, X; Liu, L; Song, G; Wang, D; Xu, H | 1 |
1 review(s) available for tadalafil and baohuoside i
| Article | Year |
|---|---|
Phosphodiesterase 5 inhibitors as novel agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cognition; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 5; Flavonoids; Humans; Neurons; Neuroprotective Agents; Phosphodiesterase 5 Inhibitors; Purinones; Pyrimidines; Signal Transduction; Sildenafil Citrate; Sulfonamides; Tadalafil; Vardenafil Dihydrochloride | 2019 |